Adjuvant Chemotherapy and Survival After Pelvic Exenteration for Gynecologic Cancers in the COREPEX Study - Top-Institutions - MDSpire

Adjuvant Chemotherapy and Survival After Pelvic Exenteration for Gynecologic Cancers in the COREPEX Study

  • By

  • Nicolò Bizzarri

  • Zoltan Novák

  • Giulio Ricotta

  • Mihai Emil Cãpîlna

  • Diana Giannarelli

  • Santiago Domingo

  • Vito Chiantera

  • Hüseyin Akıllı

  • David Cibula

  • Diana Zach

  • Andrea Miranda

  • Porfyrios Korompelis

  • Enrique Chacon

  • Ignacio Zapardiel

  • Björn Lampe

  • Valentyn Svintsitskyi

  • Olga Matylevich

  • Gabrielle H. van Ramshorst

  • Cagatay Taskiran

  • Fuat Demirkıran

  • Tibor Lengyel

  • Giuseppe Vizzielli

  • Matteo Loverro

  • Francesco Fanfani

  • Claudia Marchetti

  • Gwenael Ferron

  • Alejandra Martinez

  • Elodie Gauroy

  • Emmanuel Ladanyi

  • Leo Szilard Kiss

  • Victor Lago

  • Manel Montesinos-Albert

  • Mariano Catello Di Donna

  • Giuseppe Cucinella

  • Jiri Slama

  • Viktória Rosta

  • Mustafa Zelal Muallem

  • Ali Kucukmetin

  • Anna Fagotti

  • Sahar Salehi

  • Denis Querleu

  • June 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Leiden University Medical Centre
    Leiden University Medical Centre

    Leiden, South Holland

    Key Differentiators

    • Gynecologic Oncology

  • #2

    Complications and Recurrence After Pelvic Exenteration (COREPEX) study
    Complications and Recurrence After Pelvic Exenteration (COREPEX) study

    Not specified, Not specified

    Key Differentiators

    • Gynecologic Oncology

  • #3

    University of California, San Diego
    University of California, San Diego

    La Jolla, California

    Key Differentiators

    • Gynecologic Oncology

  • #4

    Sun Yat-sen University Cancer Center
    Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong

    Key Differentiators

    • Gynecologic Oncology

Original Source(s)

Adjuvant Chemotherapy and Survival After Pelvic Exenteration for Gynecologic Cancers in the COREPEX Study

  • by Nicolò Bizzarri, Zoltan Novák, Giulio Ricotta, Mihai Emil Cãpîlna, Diana Giannarelli, Santiago Domingo, Vito Chiantera, Hüseyin Akıllı, David Cibula, Diana Zach, Andrea Miranda, Porfyrios Korompelis, Enrique Chacon, Ignacio Zapardiel, Björn Lampe, Valentyn Svintsitskyi, Olga Matylevich, Gabrielle H. van Ramshorst, Cagatay Taskiran, Fuat Demirkıran, Tibor Lengyel, Giuseppe Vizzielli, Matteo Loverro, Francesco Fanfani, Claudia Marchetti, Gwenael Ferron, Alejandra Martinez, Elodie Gauroy, Emmanuel Ladanyi, Leo Szilard Kiss, Victor Lago, Manel Montesinos-Albert, Mariano Catello Di Donna, Giuseppe Cucinella, Jiri Slama, Viktória Rosta, Mustafa Zelal Muallem, Ali Kucukmetin, Anna Fagotti, Sahar Salehi, Denis Querleu

  • June 26, 2026

Related Content

Rebuilding cancer care in post-conflict Syria: restoring continuity across the cancer care continuum

Identification of potential vinorelbine-associated prognostic genes in breast cancer through integrative bioinformatics and experimental validation

Effectiveness of a Home-Based and Group-Based Tele-Exercise Program for Breast Cancer Survivors: Pilot Randomized Controlled Trial